Carbamic Acid

Carbamic Acid

SCHEMBL32671933

NC(=O)O.Nc1nc(-c2ccccc2)cn1C1CCCCO1

nearest known ligand 0.41

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 5/20 0.41
▸ KDM4E B2RXH2 3/20 0.41
▸ MAPT P10636 3/20 0.41
▸ PKM P14618 2/20 0.41
▸ NPC1 O15118 2/20 0.39
▸ SMN1; SMN2 Q16637 1/20 0.39
▸ ELOVL1 Q9BW60 1/20 0.39
▸ MCL1 Q07820 1/20 0.39
▸ HPGD P15428 1/20 0.38
▸ ATM Q13315 1/20 0.38
▸ LMNA P02545 4/20 0.38
▸ HTT P42858 1/20 0.38
▸ PDE8B O95263 1/20 0.38
▸ RXRA P19793 1/20 0.38
▸ RXRB P28702 1/20 0.38
▸ RXRG P48443 1/20 0.38
▸ ADORA3 P0DMS8 2/20 0.37
▸ ADORA2A P29274 2/20 0.37
▸ TSHR P16473 2/20 0.37
▸ HSD17B10 Q99714 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31202625 0.78 ALDH1A1 (0.49) ALDH1A1KDM4EMAPTPKMNPC1
SCHEMBL31202681 0.75 ACVRL1 (0.41) ALDH1A1MAPTPKMNPC1SMN1; SMN2
SCHEMBL8233363 0.71 MAPT (0.58) ALDH1A1KDM4EMAPTPKMNPC1
SCHEMBL13425961 0.67 CD274 (0.52) ALDH1A1KDM4EMAPTPKMNPC1
SCHEMBL21187503 0.67 CYP4F2 (0.43) KDM4EMAPTNPC1HPGDRXRA
SCHEMBL27037194 0.67 CNR1 (0.40) RXRARXRBRXRG
SCHEMBL3044522 0.67 CNR1 (0.40) ALDH1A1KDM4ENPC1SMN1; SMN2ELOVL1
SCHEMBL20416758 0.66 ADORA2A (0.46) ALDH1A1KDM4EMAPTNPC1SMN1; SMN2
SCHEMBL12092426 0.65 CYP4F2 (0.52) RXRARXRBRXRG
SCHEMBL11417661 0.65 NPC1 (0.46) ALDH1A1KDM4ENPC1SMN1; SMN2LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12630562-B2 Piperidylurea compounds and methods of use thereof ARCUS BIOSCIENCES, INC. (US) 2026-05-19 — — US disclosed
US-20260042777-A1 PIPERIDYLUREA COMPOUNDS AND METHODS OF USE THEREOF ARCUS BIOSCIENCES, INC. (US) 2026-02-12 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12630562-B2 Piperidylurea compounds and methods of use thereof CLIC1, HCCS, CNR1 ALDH1A1 1002/4885KDM4E 3938/4885MAPT 4783/4885
US-20260042777-A1 PIPERIDYLUREA COMPOUNDS AND METHODS OF USE THEREOF CBR1, CLIC1, RER1 ALDH1A1 1208/4885KDM4E 3441/4885MAPT 4762/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback